Furthermore, treatment of KRAS or EGFR mutant‐driven transgenic LUAD mouse models revealed that cell growth arrest induced by the HCI‐2509 inhibitor resulted in both lower tumor formation and progression in vivo. The gene discussed is KRAS; the disease is neoplasm.